HUMSCs Combined With Col I to Third-Degree Burn Wound

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18-65
SponsorThe First Affiliated Hospital of Xinxiang Medical College

About this trial

To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18-65 years, gender unrestricted

Confirmed third-degree burns, wound area 1%-5% TBSA

Admission within 72 hours after burn injury

Voluntarily signed informed consent

Disqualifiers

Pregnant or lactating females

Severe immunodeficiency or autoimmune disease

History of malignant tumor, or coagulation dysfunction

Severe cardiac, hepatic, or renal insufficiency

Trial design

Design model

Parallel

Treatments tested in this trial

  • HUMSCs combined with bovine type I collagen

    Combination product

    To evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells combined with bovine type I collagen in the treatment of third-degree burn wounds

  • bovine type I collagen

    Biological/Vaccine

    To evaluate the safety and tolerability of bovine type I collagen in the treatment of third-degree burn wounds

  • Sterile blank dressing / Vaseline gauze

    Device

    To evaluate the safety and tolerability of sterile blank dressing / vaseline gauze in the treatment of third-degree burn wounds.

Treatment groups

108 Participants
are divided into 3 treatment groups
Group A: Combination Therapy GroupExperimental treatment 1 intervention
Group B: Collagen Control GroupActive comparator 1 intervention
Group C: Placebo GroupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Re-epithelialization areas

Re-epithelialization will be determined by clinical evaluations and recorded by digital color photographs

Time frame
Up to 6 month
2

Complete burn wound healing

Time (days) to complete re-epithelialization of burned skin. It will be based on clinical evaluations and digital color photographs

Time frame
Up to 12 month

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.